Patent Assignment
Reel/Frame 060870/0825
Assignment of Assignor's Interest
Recorded: 2022-08-23
Pages: 9
Assignor
RODRIGUEZ, HECTOR M.
Executed: 2022-07-20
Assignee
ML BIO SOLUTIONS INC.
100 N. TRYON STREET, SUITE 4100, CHARLOTTE, NORTH CAROLINA, 28202
Covered Property
(1)
Detection of Dystroglycan
Application:
17/679,841 →
Publication:
US 2022/0291236
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Jan 17, 2024
From: CALCILYTIX THERAPEUTICS INC.; ADRENAS THERAPEUTICS INC.; PHOENIX TISSUE REPAIR, INC.; NAVIRE PHARMA, INC.
To: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 066342/0154 →
Security Interest
Jan 19, 2024
From: BRIDGEBIO PHARMA, INC.; QED THERAPEUTICS, INC.; EIDOS THERAPEUTICS, INC.; THERAS, INC.
To: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 066355/0126 →
Release of Security Interest in Patent Collateral
Mar 5, 2025
From: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
To: BRIDGEBIO PHARMA, INC.; QED THERAPEUTICS, INC.; EIDOS THERAPEUTICS, INC.; ML BIO SOLUTIONS INC.
Reel/Frame 070551/0095 →